Matthew Vogel

Featured in: Favicon

nature.com Favicon

ft.com

jamanetwork.com Favicon

science.org Favicon

edutopia.org Favicon

healthaffairs.org Favicon

aei.org

acpjournals.org

Articles

Differential Legal Protections for Biologics vs Small-Molecule Drugs in the US

Nov 25, 2024 | jamanetwork.com | Olivier J. Wouters |Matthew Vogel |William B. Feldman |Aaron S. Kesselheim

Differential Legal Protections for Biologics vs Small-Molecule Drugs in the US Abstract Importance Biologics approved by the US Food and Drug Administration (FDA) receive 12 years of guaranteed protection from biosimilar competition compared with 5 years of protection from generic competition for new small-molecule drugs.
Strategies for Creating an Effective Co-teaching Relationship

May 13, 2024 | edutopia.org | Matthew Vogel

Throughout my career as a special education teacher, I’ve had many opportunities to co-teach in collaborative classrooms. Some of these experiences were positive, others more challenging. With the ever-increasing demands of today’s classrooms, many school districts are relying on co-teaching to meet the needs of all learners. Yet teachers aren’t often trained in co-facilitation. It’s important to fill this gap. Below, I offer insights on how to begin.
Medicare Negotiation’s Drug Reformulation Problem

Apr 30, 2024 | acpjournals.org | Matthew Vogel

Metrics & Citations If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download. For more information or tips please see 'Downloading to a citation manager' in the Help menu.
Biopharma Venture Capital And The Inflation Reduction Act

Mar 5, 2024 | aei.org | Amitabh Chandra |Matthew Vogel |Rena Conti

The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first expected to result in a net reduction in Medicare drug costs. Although beneficial for today’s payers and patients, the magnitude of the law’s effect on future innovation is disputed. The Congressional Budget Office (CBO) estimated that the IRA will result in a decrease of one new drug in the first decade and an additional 12 drugs over the following two decades.
Biopharma Venture Capital And The Inflation Reduction Act

Mar 5, 2024 | healthaffairs.org | Matthew Vogel |Rena Conti |Amitabh Chandra

The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first expected to result in a net reduction in Medicare drug costs. Although beneficial for today’s payers and patients, the magnitude of the law’s effect on future innovation is disputed. The Congressional Budget Office (CBO) estimated that the IRA will result in a decrease of one new drug in the first decade and an additional 12 drugs over the following two decades.
Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction Act - Nature Biotechnology

Jan 31, 2024 | nature.com | Matthew Vogel

AbstractThe Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA’s negotiation criteria retrospectively, we identify all drugs that met the eligibility criteria from 2012 to 2021 to classify drugs that would have had a negotiated price in effect in 2022 and to calculate associated decreases in industry revenues.
Guiding Students to Craft Disability Disclosure Letters to Support Their Transition to College

Jan 26, 2024 | edutopia.org | Matthew Vogel

Several years ago, I was a professor of Special Education at a small private university in Western Pennsylvania. Before the start of the fall semester, I received an email from a student who was enrolled in my course, Introduction to the Teaching Profession. In his email, the student provided some background information about his hometown, activities, and professional goals.
Preparing Students With Disabilities for the Transition to College

Jan 3, 2024 | edutopia.org | Matthew Vogel

Statistics indicate that 55 percent of students diagnosed with a disability continue their education in a postsecondary setting. Information critical to postsecondary success, however, is rarely taught to students with disabilities. Below, I outline key information about differences in disability accommodation in K–12 and postsecondary environments. I then share activities that teachers can use to acquaint students with applicable policies and prepare them to navigate systemic complexities.
Cost of Exempting Sole Orphan Drugs From Medicare Negotiation

Nov 27, 2023 | jamanetwork.com | Matthew Vogel |Olivia Zhao |William B. Feldman |Amitabh Chandra

Cost of Exempting Sole Orphan Drugs From Medicare Negotiation Key PointsQuestion What are the costs of the exemption from Medicare price negotiation under the Inflation Reduction Act for drugs approved solely for the treatment of a single rare disease? Findings This cross-sectional study identified 25 “sole orphan” drugs qualifying for exemption from Medicare price negotiation.